CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 27 enrolled
Drug / intervention
exerciseother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02006979
NCT02006979Phase 1Completed

The Effects of Exercise Before Doxorubicin Chemotherapy on Cardiac Function

University of British Columbia·interventional·Posted Dec 10, 2013·Updated Oct 25, 2019

In Brief

A Phase 1 clinical trial evaluating exercise for Breast Cancer. Completed, enrolled 27 participants across 1 site.

Detailed Summary

In rodents, a single bout of exercise prior to injection of a chemotherapy agent used to treat breast cancer prevents or attenuates a number of markers of cardiac injury. This study will investigate whether this finding translates to human breast cancer patients. Participants scheduled to receive chemotherapy for breast cancer will be randomized to exercise or no exercise 24 hours prior to every chemotherapy treatment. The effect on cardiac function will be compared between groups noninvasively by echocardiography and electrocardiography and a venous blood draw at baseline before chemotherapy, after the first treatment and at the end of chemotherapy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesCanada

Timeline

Phase 1CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedDec 10, 2013
Enrollment StartJan 15, 2016
Primary CompletionMay 25, 2016
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 12.6 years ago

Interventions

exerciseother

An acute bout of exercise performed 24 hours prior to every anthracycline infusion.